We've made it easier for you to connect! Fill out your NEW profile.
HER2-Positive Brain Mets Respond to Enhertu
moderators
Posts: 8,934
HER2-Positive Brain Mets Respond to Enhertu
September 12, 2014
The targeted therapy Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) helped control areas of metastatic HER2-positive breast cancer in the brain, according to results from the DESTINY-Breast12 study presented on Sept. 13 at ESMO 2024. Read more…
1
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.